BIOMAT Database Logo BIOMAT Database Logo

IgA nephropathy: immunogenetic studies of Australian patients. 1995

J F Knight, and M C Falk, and C Ng, and G C Fanning, and C M Artlett, and L P Roy
Renal Research Laboratory, Royal Alexandra Hospital for Children, Capmerdown, N.S.W., Australia.

UI MeSH Term Description Entries
D007143 Immunoglobulin Heavy Chains The largest of polypeptide chains comprising immunoglobulins. They contain 450 to 600 amino acid residues per chain, and have molecular weights of 51-72 kDa. Immunoglobulins, Heavy-Chain,Heavy-Chain Immunoglobulins,Ig Heavy Chains,Immunoglobulin Heavy Chain,Immunoglobulin Heavy Chain Subgroup VH-I,Immunoglobulin Heavy Chain Subgroup VH-III,Heavy Chain Immunoglobulins,Heavy Chain, Immunoglobulin,Heavy Chains, Ig,Heavy Chains, Immunoglobulin,Immunoglobulin Heavy Chain Subgroup VH I,Immunoglobulin Heavy Chain Subgroup VH III,Immunoglobulins, Heavy Chain
D011415 Complement Factor B A glycine-rich, heat-labile serum glycoprotein that contains a component of the C3 CONVERTASE ALTERNATE PATHWAY (C3bBb). Bb, a serine protease, is generated when factor B is cleaved by COMPLEMENT FACTOR D into Ba and Bb. C3 Proactivator,C3PA,Complement 3 Proactivator,Factor B,Properdin Factor B,Bb Fragment of Factor B,Complement Factor B Fragment, Bb,Complement Factor B, Alternative Pathway,Complement Factor B-Derived Fragment Bb,Complement Factor Ba,Complement Factor Bb,Complement Protein B,Complement Protein Factor B,Properdin Factor Ba,Properdin Factor Bb,Properdin Factor Bf,Properdin Factor Bf F1,Bb, Complement Factor,Complement Factor B Derived Fragment Bb,Factor B, Complement,Factor B, Properdin,Factor Ba, Complement,Factor Ba, Properdin,Factor Bb, Complement,Factor Bb, Properdin,Factor Bf, Properdin,Proactivator, C3,Proactivator, Complement 3,Protein B, Complement
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D003181 Complement C4 A glycoprotein that is important in the activation of CLASSICAL COMPLEMENT PATHWAY. C4 is cleaved by the activated COMPLEMENT C1S into COMPLEMENT C4A and COMPLEMENT C4B. C4 Complement,C4 Complement Component,Complement 4,Complement C4, Precursor,Complement Component 4,Pro-C4,Pro-complement 4,C4, Complement,Complement Component, C4,Complement, C4,Component 4, Complement,Component, C4 Complement,Pro C4,Pro complement 4
D004198 Disease Susceptibility A constitution or condition of the body which makes the tissues react in special ways to certain extrinsic stimuli and thus tends to make the individual more than usually susceptible to certain diseases. Diathesis,Susceptibility, Disease,Diatheses,Disease Susceptibilities,Susceptibilities, Disease
D005803 Genes, Immunoglobulin Genes encoding the different subunits of the IMMUNOGLOBULINS, for example the IMMUNOGLOBULIN LIGHT CHAIN GENES and the IMMUNOGLOBULIN HEAVY CHAIN GENES. The heavy and light immunoglobulin genes are present as gene segments in the germline cells. The completed genes are created when the segments are shuffled and assembled (B-LYMPHOCYTE GENE REARRANGEMENT) during B-LYMPHOCYTE maturation. The gene segments of the human light and heavy chain germline genes are symbolized V (variable), J (joining) and C (constant). The heavy chain germline genes have an additional segment D (diversity). Genes, Ig,Immunoglobulin Genes,Gene, Ig,Gene, Immunoglobulin,Ig Gene,Ig Genes,Immunoglobulin Gene
D005812 Genes, Switch Genes that cause the epigenotype (i.e., the interrelated developmental pathways through which the adult organism is realized) to switch to an alternate cell lineage-related pathway. Switch complexes control the expression of normal functional development as well as oncogenic transformation. Switch Genes,Switching Complex,Switch Complexes,Switching Complexes,Complex, Switching,Complexes, Switch,Complexes, Switching,Gene, Switch,Switch Gene
D005922 Glomerulonephritis, IGA A chronic form of glomerulonephritis characterized by deposits of predominantly IMMUNOGLOBULIN A in the mesangial area (GLOMERULAR MESANGIUM). Deposits of COMPLEMENT C3 and IMMUNOGLOBULIN G are also often found. Clinical features may progress from asymptomatic HEMATURIA to END-STAGE KIDNEY DISEASE. Berger Disease,Immunoglobulin A Nephropathy,Nephropathy, IGA,Berger's Disease,IGA Glomerulonephritis,IGA Nephropathy,Iga Nephropathy 1,Nephritis, IGA Type,Bergers Disease,Glomerulonephritides, IGA,IGA Type Nephritis,Nephropathy 1, Iga,Nephropathy, Immunoglobulin A
D006683 HLA-DQ Antigens A group of the D-related HLA antigens found to differ from the DR antigens in genetic locus and therefore inheritance. These antigens are polymorphic glycoproteins comprising alpha and beta chains and are found on lymphoid and other cells, often associated with certain diseases. HLA-DC Antigens,HLA-MB Antigens,HLA-DC,HLA-DQ,HLA-DS,HLA-DS Antigens,HLA-LB,HLA-LB Antigens,HLA-MB,Antigens, HLA-DC,Antigens, HLA-DQ,Antigens, HLA-DS,Antigens, HLA-LB,Antigens, HLA-MB,HLA DC Antigens,HLA DQ Antigens,HLA DS Antigens,HLA LB Antigens,HLA MB Antigens
D006684 HLA-DR Antigens A subclass of HLA-D antigens that consist of alpha and beta chains. The inheritance of HLA-DR antigens differs from that of the HLA-DQ ANTIGENS and HLA-DP ANTIGENS. HLA-DR,Antigens, HLA-DR,HLA DR Antigens

Related Publications

J F Knight, and M C Falk, and C Ng, and G C Fanning, and C M Artlett, and L P Roy
Immunogenetic aspects of primary IgA nephropathy.
December 1995, Kidney international,
J F Knight, and M C Falk, and C Ng, and G C Fanning, and C M Artlett, and L P Roy
Immunogenetic differences in subpopulations of patients with IgA nephropathy (Berger's disease).
January 1984, Experimental and clinical immunogenetics,
J F Knight, and M C Falk, and C Ng, and G C Fanning, and C M Artlett, and L P Roy
Familial clustering and immunogenetic aspects of IgA nephropathy.
November 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation,
J F Knight, and M C Falk, and C Ng, and G C Fanning, and C M Artlett, and L P Roy
Immunogenetic markers as prognostic features in patients from Kentucky with IgA nephropathy.
December 1987, Seminars in nephrology,
J F Knight, and M C Falk, and C Ng, and G C Fanning, and C M Artlett, and L P Roy
Immunoregulatory studies in patients with IgA nephropathy.
March 1988, Journal of clinical & laboratory immunology,
J F Knight, and M C Falk, and C Ng, and G C Fanning, and C M Artlett, and L P Roy
Studies on IgA antiglobulins in IgA nephropathy.
December 1987, Seminars in nephrology,
J F Knight, and M C Falk, and C Ng, and G C Fanning, and C M Artlett, and L P Roy
Genetic studies of IgA nephropathy.
January 2006, Nephron. Experimental nephrology,
J F Knight, and M C Falk, and C Ng, and G C Fanning, and C M Artlett, and L P Roy
[Clinicopathological studies of IgA nephropathy].
June 1977, Nihon rinsho. Japanese journal of clinical medicine,
J F Knight, and M C Falk, and C Ng, and G C Fanning, and C M Artlett, and L P Roy
Immunologic studies in IgA nephropathy.
September 1980, Kidney international,
J F Knight, and M C Falk, and C Ng, and G C Fanning, and C M Artlett, and L P Roy
IgA antibodies to dietary antigens and lectin-binding IgA in sera from Italian, Australian, and Japanese IgA nephropathy patients.
April 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation,
Copied contents to your clipboard!